Company Profile
CoDa Therapeutics is a biopharmaceutical company with a unique, patented approach to wound healing. The company is focused on the development and commercialization of therapeutics for wound care and tissue repair based on a new platform technology known as “Gap Junction Modulation.”
- Founded on inventions and data generated in the laboratories of Professor Colin Green (University of Auckland) and Dr. David Becker (University College London)
- Building a portfolio of novel, proprietary compounds that reduce cell-to-cell communication and improve wound healing and tissue repair post-injury
- CoDa’s patent-protected lead product candidate, Nexagon™, dramatically improves the body's ability to repair damaged tissue and has numerous broad applications
